 - Previous or concurrent cancer that is distinct in primary site or histology from breast cancer within 5 years prior to enrollment EXCEPT cervical cancer in situ, treated basal cell carcinoma, squamous cell carcinoma SCC, as long as it is other than SCC involving skin of the head andor neck, and superficial bladder tumors Ta and Tis. 